Akoya Biosciences Inc [AKYA] stock prices are up 18.75% to $1.33 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AKYA shares have gain 16.67% over the last week, with a monthly amount glided 20.91%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Akoya Biosciences Inc [NASDAQ: AKYA] stock has seen the most recent analyst activity on November 15, 2024, when Craig Hallum downgraded its rating to a Hold and also revised its price target to $5 from $7. Previously, Morgan Stanley downgraded its rating to Equal-Weight on August 06, 2024. On August 06, 2024, downgrade downgraded it’s rating to Neutral. BTIG Research downgraded its rating to a Neutral. Craig Hallum initiated its recommendation with a Buy and recommended $7.50 as its price target on June 21, 2024.
The stock price of Akoya Biosciences Inc [AKYA] has been fluctuating between $0.93 and $3.42 over the past year. Currently, Wall Street analysts expect the stock to reach $2.4 within the next 12 months. Akoya Biosciences Inc [NASDAQ: AKYA] shares were valued at $1.33 at the most recent close of the market. An investor can expect a potential return of 80.45% based on the average AKYA price forecast.
Analyzing the AKYA fundamentals
The Akoya Biosciences Inc [NASDAQ:AKYA] reported sales of 79.96M for trailing twelve months, representing a drop of -9.32%. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -0.48%, Pretax Profit Margin comes in at -0.59%, and Net Profit Margin reading is -0.59%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is -5.06 and Total Capital is -8.44. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-14.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Akoya Biosciences Inc [NASDAQ:AKYA]’s Current Ratio is 0.61. Also, the Quick Ratio is 0.40, while the Cash Ratio stands at 0.19. Considering the valuation of this stock, the price to sales ratio is 0.83.
